References
- Bosl GJ, Motzer RJ. Testicular germ- cell cancer. N Engl J Med 1997; 337(4): 242–53
- Bosl GJ, Bajorin DF, Sheinfeld J, et al. Cancer of the testis. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles & practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997: 1397–426
- Einhorn LH. Testicular cancer as a model for a curable neoplasm: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1981; 41(9 Pt 1): 3275–80
- O'Callaghan A, Mead GM. Testicular carcinoma. Postgrad Med J 1997; 73 (862): 481–6
- Nichols CR, Heerema NA, Palmer C, et al. Klinefelter's syndrome associated with mediastinal germ cell neoplasms. J Clin Oncol 1987; 5(8): 1290–4
- Dieckmann KP, Pichlmeier U. The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature. Cancer 1997; 80(10): 1954–60
- Nichols CR, Roth BJ, Heerema N, et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990; 322(20): 1425–9
- Chaganti RS, Rodriguez E, Bosl GJ. Cytogenetics of male germ-cell tumors. Urol Clin North Am 1993; 20(l): 55–66
- International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15(2): 594–603
- Donohue JP, Thornhill JA, Foster RS, et al. Primary retroperitoneal lymph node dissection in clinical stage A nonseminomatous germ cell testis cancer: review of the Indiana University experience 1965–1989. Br J Urol 1993; 71(3): 326–35
- Williams SD, Stablein DM, Einhorn LH, et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987; 317(23): 1433–8
- Einhorn LH, Williams SD, Loehrer PJ, et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol 1989; 7(3): 387–91
- Williams SD, Birch R, Einhorn LH, et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987; 316(23): 1435–40
- Warde P, Gospodarowicz MK, Panzarella T, et al. Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol 1995; 13(9): 2255–62
- Schultz SM, Einhorn LH, Conces DJ Jr, et al. Management of postchemother-apy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 1989; 7(10): 1497–503
- Einhorn LH, Weathers T, Loehrer PJ, et al. Long term follow up of second line chemotherapy with vinblastine, ifos-famide and cisplatin in disseminated germ cell tumors. (Abstr) Proc ASCO 1996; 15(May): 240
- Broun ER, Nichols CR, Gize G, et al. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer. Cancer 1997; 79(8): 1605–10
- Baniel J, Foster RS, Gonin R, et al. Late relapse of testicular cancer. J Clin Oncol 1995; 13(5): 1170–6
- Nichols CR, Breeden ES, Loehrer PJ, et al. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. J Natl Cancer Inst 1993; 85(l): 36–40